[Tumor-induced hypophosphatemic osteomalacia].
Ito
Nobuaki
N
Fukukmoto
Seiji
S
D002117:Calcitriol / Q000097:blood; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000502:physiology; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage; D017674:Hypophosphatemia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D009369:Neoplasms / Q000150:complications*; D010018:Osteomalacia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D010710:Phosphates / Q000008:administration & dosage; D011379:Prognosis
D006887:Hydroxycholecalciferols; D010710:Phosphates; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D002117:Calcitriol; C008088:alfacalcidol